ArticleVirchows Archiv : an international journal of pathology2026
Cervical HPV-independent adenosquamous carcinoma: report of a case series.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenosquamous carcinoma is an uncommon cervical malignancy which is composed of a morphologically recognisable malignant squamous and glandular component. In the current 5th edition WHO Classification of Female Genital Tumours, adenosquamous carcinoma of the cervix is regarded as a high-risk human papillomavirus (HPV)-associated neoplasm. However, in recent years, there have been occasional reports of cervical HPV-independent adenosquamous carcinomas. We report a series of 5 cervical HPV-independent adenosquamous carcinomas in women aged 45 to 68 years; 4 of 5 patients were postmenopausal. The percentage of the squamous component ranged from 10 to 90%. In all cases, the glandular component was gastric-type. All tumours exhibited negative/non-block-type staining with p16 and were also negative for HPV on molecular testing. Molecular testing (4 of 5 cases) revealed no recurrent variants. However, in individual cases, pathogenic or likely pathogenic variants were present in BRAF, CDK12, RB1, FGFR2, FGFR3, BRCA1, KRAS, CDKN1A, CDKN2A, TP53, and STK11. In addition, deletions of CDKN2A/CDKN2B and TP53 were present in 1 case. The tumours were advanced stage at diagnosis: stage IIB (1 case), IIIC1 (2 cases), and IVB (2 cases). Our findings suggest that cervical adenosquamous carcinoma should be classified into HPV-associated and HPV-independent types and this should be reflected in updated WHO Classifications.
Indexed as
Identifiers
41569320What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.